mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |